Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4556441
Max Phase: Preclinical
Molecular Formula: C39H46F3N7O8
Molecular Weight: 797.83
Molecule Type: Unknown
Associated Items:
ID: ALA4556441
Max Phase: Preclinical
Molecular Formula: C39H46F3N7O8
Molecular Weight: 797.83
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccc(NC(=O)N[C@@H](Cc2cc(F)cc(F)c2)C(=O)N[C@H]2COC(=O)[C@@H]3C[C@@H](F)CN3C(=O)[C@H](C)NC(=O)[C@@H]3CCCCN3C(=O)[C@@H]3CCCN3C2=O)cc1
Standard InChI: InChI=1S/C39H46F3N7O8/c1-21-8-10-27(11-9-21)44-39(56)46-28(16-23-14-24(40)17-25(41)15-23)33(50)45-29-20-57-38(55)32-18-26(42)19-49(32)35(52)22(2)43-34(51)30-6-3-4-12-47(30)37(54)31-7-5-13-48(31)36(29)53/h8-11,14-15,17,22,26,28-32H,3-7,12-13,16,18-20H2,1-2H3,(H,43,51)(H,45,50)(H2,44,46,56)/t22-,26+,28-,29-,30-,31-,32-/m0/s1
Standard InChI Key: ZUAOLTHDGJCIFZ-MSIAEKDKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 797.83 | Molecular Weight (Monoisotopic): 797.3360 | AlogP: 1.86 | #Rotatable Bonds: 6 |
Polar Surface Area: 186.56 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 15 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.04 | CX Basic pKa: | CX LogP: 1.54 | CX LogD: 1.54 |
Aromatic Rings: 2 | Heavy Atoms: 57 | QED Weighted: 0.32 | Np Likeness Score: -0.19 |
1. (2018) Substituted urea depsipeptide analogs as activators of the clpp endopeptidase, |
Source(1):